![Rajiv Amin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rajiv Amin
No más puestos en curso
Fortuna: - $ al 31/03/2024
Perfil
Rajiv Amin worked as a Senior Director of Financial Reporting at Alvogen, Inc. and Kyowa Kirin, Inc. He also worked as a Controller-Americas at Convatec Group Plc.
Amin received his undergraduate degree from the University of Scranton and his graduate degree from Babson College.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
10/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Antiguos cargos conocidos de Rajiv Amin.
Empresas | Cargo | Fin |
---|---|---|
Alvogen, Inc.
![]() Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Corporate Officer/Principal | - |
Kyowa Kirin, Inc. | Corporate Officer/Principal | - |
CONVATEC GROUP PLC | Corporate Officer/Principal | - |
IPI LEGACY LIQUIDATION CO | Director Financiero/CFO | 10/05/2023 |
Formación de Rajiv Amin.
Babson College | Graduate Degree |
University of Scranton | Undergraduate Degree |
Experiencias
Funciones ocupadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
IPI LEGACY LIQUIDATION CO | Health Technology |
CONVATEC GROUP PLC | Health Technology |
Empresas privadas | 2 |
---|---|
Kyowa Kirin, Inc. | |
Alvogen, Inc.
![]() Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Rajiv Amin